AOOSIS’ Post

Show off your excellence! 🏆 Submissions are now open for the BOMA 2025 TOBYs! Click the links in our bio under “BOMA 2025 TOBYs” for more information on registration, nominations and our TOBYs masterclass! #IAmBOMANv #BOMANv #realestatetips⁠ #realestateeducation

✨ Looking Back at 2024: A Key Year for Genomnis ✨   As 2025 begins, we wanted to share the highlights of 2024, a year of innovation and growth for Genomnis.   🌐 Launch of Our New Website   A completely redesigned website, more intuitive and informative, providing a detailed overview of our solutions and tools to better serve our users.   🎉 Introducing Our New CANDICE Solution Collaborative ANnotation Database with an Interpretation and Classification Expert system   CANDICE is an innovative tool for the annotation and analysis of genetic variants and CNVs, transforming research and diagnostic processes. It provides an enhanced user experience and advanced features that enable researchers, clinicians and healthcare professionals to quickly identify relevant genetic variations for informed decision-making.   CANDICE offers the possibility to perform complex analyses on data from NGS or CGH Array, in VCF format (SNVs, CNVs) or in the format provided by Agilent's Cytogenomics software (CNVs). Beyond the simple analysis of the index case, the system allows the analysis of trios or complex families with the construction of a family tree. Furthermore, thanks to its advanced search module, CANDICE allows the creation of cohorts of patients that can then be analyzed to detect common variants of interest or common genes, and to perform Burden tests.   In addition, one of its key innovations is automated SNV and CNV classification, which streamlines and accelerates the interpretation of genetic data, making it a powerful resource for healthcare professionals.   Interested in learning more? You can request a demo on our website to explore the full potential of CANDICE. ➡️ https://lnkd.in/eDMmW3-M   🧬 Major Update of Our ExoSplice Tool   ExoSplice's algorithms have been carefully improved and revised to provide users with even greater accuracy and performance. Researchers and clinicians now have access to a fast, reliable and precise solution for developing targeted therapeutic strategies.   We have also launched a new module designed to revolutionize pseudo-exon correction. Using cutting-edge algorithms and an intuitive interface, ExoSplice automates the generation and prioritization of antisense oligonucleotides (AONs), customized for any given pseudo-exon.   ✨ Thank You! We would like to thank our partners, customers and teams for their trust and support throughout 2024. We look forward to continuing this exciting journey with you in 2025! #Innovation #Genetics #Genomics #Bioinformatics #CANDICE #CNVanalysis #CNVs #ExoSplice #ExonSkipping #AON #Therapy #PseudoExon Marseille Innovation

🎥 𝗕𝗲𝗵𝗶𝗻𝗱 𝘁𝗵𝗲 𝘀𝗰𝗲𝗻𝗲𝘀 𝗮𝘁 𝗠𝗲𝗱 𝗢𝗻𝗲! Our new Mini Mic Series is here to introduce you to some of our incredible team members. First up, they're sharing their favorite part of working here. Comment below what you love about Med One! #MedOne #MedOneFamily #MedOneMiniMic

Need nCino Resources? Obrimo Has Got You Covered! 😬 Looking for expert guidance, or support for nCino? Obrimo offers tailored solutions to help you maximize the potential of the nCino platform. • Custom Implementation & Integration • Ongoing Support & Optimization Reach out to Obrimo today and take your nCino experience to the next level! Apoorva A. Jasmeet Kaur Nidhi Chauhan Obrimo Technologies (Formerly known as Salecino)

Bringing the future to your lab 🥼 #Epredia By integrating automation and AI-driven insights, Epredia is not just improving efficiency, but also bringing the future of cancer care to the forefront, giving pathologists the tools they need to save lives with greater precision and confidence. At the heart of successful Pathology labs 🎗️

Excited for the upcoming #ISVIR Masterclass led by Dr. Uday Limaye sir, focusing on Brain AVM - case based discussion. 🧠💼 Mark your calendars for today 7 pm - an unmissable opportunity for valuable insights!💡 #IR #ISVIR

Excited to share the latest article highlighting my PhD thesis findings on alleviating Parkinson’s motor issues using Vilazodone. I hope these findings contribute to advancing treatment options and improving the quality of life for Parkinson’s patients. Check out the article for more insights! #ParkinsonsResearch #Vilazodone

🎯 Create motivating customized challenges for patients 🎵 Sync therapy with music to boost motivation 📈 Personalized training, see results and progress #Rehabilitation #GaitTherapy #LokomatPro #Hocoma

🧬 ExoSplice revolutionizes pseudo-exon correction 🧬 Alternative splicing is a fundamental mechanism for regulating gene expression, enabling the production of multiple protein isoforms from a single gene. However, anomalies in this process, such as the inclusion of pseudo-exons, can lead to serious dysfunction. Excluding these pseudo-exons using exon-skipping approaches is a real solution, and ExoSplice is here to help. #ExonSkipping #AON #Therapy #Genetics #Genomics #Bioinformatics #Innovation #PseudoExon

Your Voice Matters! 🫵🏼 Hopefully, you’ve recovered from the classic "Davos flu" and are shaking off the post-Davos slowdown. But now is the time to reflect. Now is the time to act. Now is the time to turn the energy and connections from last week into real, tangible impact. Help shape unDavos 2026 with us. At unDavos, we believe in co-creation. This movement is built by the people who show up, challenge the status quo, and push for change. That’s why we want your feedback. What worked? What could be improved? How can we make unDavos 2026 even more inclusive, action-driven, and impactful? 📝 Take a few minutes to share your thoughts with us: https://lnkd.in/dd9hGAXi The dates for 2026 are set – January 19-23. Let’s make next year even bigger, bolder, and more impactful. #unDavos2025 #unDavos2026 #CoCreatingChange #CollaborationForImpact #ShapingTheFuture #ItAllChanges